Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Cornea and External Disease
What has been your experience with netarsudil in the management of corneal edema, particularly concerning its clinical effectiveness and insurance coverage?
Related Questions
How would you approach the management of a patient presenting with bilateral central corneal perforations following treatment with Ipilimumab/Nivolumab?
How do you approach IOL exchange in a patient who is unhappy after cataract surgery with a premium IOL?
When do you consider performing laser refractive surgery on corneal transplants?
What is the best course of treatment for limbal stem cell deficiency with a perforated corneal ulcer?
How do you decide on treatment modality for ocular surface squamous neoplasia?
What strategies do you use to optimize cataract surgery outcomes in patients with anterior basement membrane dystrophy (ABMD)?
How do you approach the use of Cequa in eyes with severe corneal thinning from a prior, healed corneal ulcer?
What alternative treatments are available for refractory filamentary keratitis in a patient for whom bandage contact lenses provide the only relief and who has failed cyclosporine and N-acetylcysteine drops?
When should mitomycin intravascular chemoembolization be considered as a treatment for corneal neovascularization?
Which IOL do you prefer for patients with a history of hyperopic LASIK to minimize the risk of inducing spherical aberration?
